Search

Author/Creator Dubey, Sarita

1. Adjuvant atezolizumab versus placebo for patients with renal cell carcinoma at increased risk of recurrence following resection (IMmotion010): a multicentre, randomised, double-blind, phase 3 trial. Issue 10358 (1st October 2022)

Authors:
Pal, Sumanta Kumar; Uzzo, Robert; Karam, Jose Antonio; Master, Viraj A; Donskov, Frede; Suarez, Cristina; Albiges, Laurence; Rini, Brian; Tomita, Yoshihiko; Kann, Ariel Galapo; Procopio, Giuseppe; Massari, Francesco; Zibelman, Matthew; Antonyan, Igor; Huseni, Mahrukh; Basu, Debasmita; Ci, Bo; Leu...
Journal:
Lancet
Issue:
Volume 400:Issue 10358(2022)
Page Start:
1103
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Cabozantinib in Combination With Atezolizumab for Advanced Renal Cell Carcinoma: Results From the COSMIC-021 Study. Issue 33 (20th November 2021)

Authors:
Pal, Sumanta K.; McGregor, Bradley; Suárez, Cristina; Tsao, Che-Kai; Kelly, William; Vaishampayan, Ulka; Pagliaro, Lance; Maughan, Benjamin L.; Loriot, Yohann; Castellano, Daniel; Srinivas, Sandy; McKay, Rana R.; Dreicer, Robert; Hutson, Thomas; Dubey, Sarita; Werneke, Scott; Panneerselvam, Ashok...
Journal:
Journal of clinical oncology
Issue:
Volume 39:Issue 33(2021)
Page Start:
3725
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search